Odomzo (sonidegib) — Medica
Basal cell carcinoma, locally advanced
Initial criteria
- Patient is ≥ 18 years of age
- Patient has recurrent basal cell carcinoma following surgery or radiation therapy OR patient is not a candidate for surgery AND according to the prescriber is not a candidate for radiation therapy
Reauthorization criteria
- Patient is currently receiving Odomzo
Approval duration
1 year